To analyze the variations in cost of Anti-glaucoma eye preparations available in Indian market

Abstract

Aim: To analyze the percentage cost variations among different brands of the commonly prescribed anti–glaucoma drugs. Material and Methods: The maximum and minimum price of each brand of the drug in INR was noted by using CIMS January to April 2018 edition Drug Today April to June 2018 Vol-1. The cost ratio and the percentage cost variation for individual drug brands was calculated. The cost of each eye drop was calculated. At last the cost ratio and percentage cost variation of various brands was compared. Results:Percentage variation in cost for anti-glaucoma eye preparations marketed in India was found to be Eye drop Timolol maleate (0.5%) of 5ml:263.63, Eye drop Dorzolamide (2%) of 5ml:9.77, Eye drop Pilocarpine (2%) of 5ml:160.40, Eye drop Betaxolol (0.5%) of 5ml:56.54, Eye drop Latanoprost(50mcg/ml) of 2.5ml:135.88, Eye drop Brimonidine tartarate (0.15%) of 5ml:183.9, Eye drop Levobunolol (5mg/ml) of 5ml:32.38, Conclusion:Glaucoma is the most common ocular disease and eye drops are to be prescribed for prolonged period. If a costly brand is prescribed, the patients have to pay more money unnecessarily for their treatment. The clinicians prescribing these drugs should be aware of these variations in cost to reduce the cost of drug therapy. Keywords: Glaucoma, Percentage cost variation, Cost ratio.